News
News

News

05/12/2020 STRATA Skin Sciences Reports First Quarter 2020 Financial Results

STRATA Skin Sciences Reports First Quarter 2020 Financial Results

Recurring revenue for the first quarter of 2020 grew 7.3% over first quarter 2019 Total gross margins in the first quarter of 2020 grew 3.8% over first quarter 2019  Global recurring revenue installed base totaled 838 systems at March 31, 2020 Conference call and webcast, today at 8:30 am Eastern
05/05/2020 STRATA Skin Sciences to Host First Quarter 2020 Financial Results and Business Update Conference Call on May 12

STRATA Skin Sciences to Host First Quarter 2020 Financial Results and Business Update Conference Call on May 12

HORSHAM, Pa. , May 05, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
04/27/2020 STRATA Skin Sciences, Inc. Receives Forgivable Loan Under the Paycheck Protection Program

STRATA Skin Sciences, Inc. Receives Forgivable Loan Under the Paycheck Protection Program

$2.0 million forgivable loan received Provides further business update - Initiating the Patient Outreach Program HORSHAM, Pa. , April 27, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery
03/10/2020 STRATA Skin Sciences to Host Fourth Quarter and Year End 2019 Financial Results and Business Update Conference call on March 17

STRATA Skin Sciences to Host Fourth Quarter and Year End 2019 Financial Results and Business Update Conference call on March 17

HORSHAM, Pa. , March 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
01/23/2020 STRATA Skin Sciences, Inc. Receives A 510(k) Clearance For Its XTRAC Momentum 308nm Excimer Laser Platform

STRATA Skin Sciences, Inc. Receives A 510(k) Clearance For Its XTRAC Momentum 308nm Excimer Laser Platform

New features include increased power range, short-hair scalp tip and on-board database to improve patient safety, treatment efficiency and ease-of-use HORSHAM, Pa. , Jan. 23, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company
01/13/2020 STRATA Skin Sciences, Inc. Announces Preliminary Q4 FY 2019 Revenue and Key Financial Metrics

STRATA Skin Sciences, Inc. Announces Preliminary Q4 FY 2019 Revenue and Key Financial Metrics

Preliminary, unaudited fourth quarter revenues in the range of $8.8 million to $8.85 million Preliminary, unaudited fourth quarter recurring revenues in the range of $6.5 million to $6.55 million Preliminary, unaudited fourth quarter revenues result in double digit growth Domestic installed base